ETFs, Leveraged ETFs, Sector Funds

[No-Quarter]

In the past, October has been a turbulent month for the market. The below article suggests this year will be similar, and a re-entry point for me will present itself soon.

http://www.marketwatch.com/story/get-ready-for-the-bulls-to-be-tested-2015-10-12

"The next two weeks will confirm for us whether we see our next bigger drop towards the 1700s, or whether...we are heading over 2300 sooner rather than later."

"After all the dust settles as to which path the market will take for the rest of October, once November rolls in, we should have an opportunity to go long the market one way or another for a target of 2300-plus. The next two weeks in October hold the key to how and from where we begin the next rally phase to 2300-plus."

...and here is an article suggesting FSPHX again be the fund I buy.

http://www.marketwatch.com/story/biotechs-close-in-on-a-bottom-and-a-buying-opportunity-2015-10-13?link=MW_TD

"Once biotech stocks do find a bottom, I expect the strong upward trend to continue,... Based on this analysis, I believe that investors should be viewing this correction as an opportunity to buy, looking past the current depressed sentiment."

GLTY